Neonatal hyaline membrane disease (HMD) is an acute condition that occurs in newborns in the first days of life when their respiratory system and immune system are immature. BHM occurs as a result of damage to the lungs and the membrane of the air exchange system of the newborn. The disease is diagnosed by clinical signs such as shallow breathing, wheezing, cyanosis (blue discoloration of the skin), cough and decreased physical activity. Treatment includes monitoring body temperature, using antibiotics and mechanical ventilation to support breathing.
Hyaline membrane disease of newborns is a pathology that occurs due to underdevelopment of the lungs in children under one year of age. It is characterized by hypoxia of internal organs and postpartum asphyxia syndrome. This disease has a very high mortality rate. Among the causes of the development of hyaline membrane disease are the following: · Hypothermia of the child during or immediately after birth; · Underdevelopment of the lungs in infants;
The hyaline membrane, or hyaline tissue membrane, forms on the surface of the mucous membrane of the respiratory tract and clogs the lumen of the alveoli of the lungs, which leads to a disruption in the supply of oxygen to cells. The most common symptoms of glialin membrane are severe respiratory failure, leading to decreased oxygen levels in the blood, and intoxication of the body.
Treatment of hyaline membrane disease when complicated by an advanced stage of its course is the main factor influencing the length of hospital stay. At the moment, experts are developing treatment methods to prevent the progression of the disease outside the hospital, since today children receive the necessary medical care during pregnancy or childbirth, and since it is at this time that it is necessary to treat the baby for hyaline disease. A severe form of the disease can lead to the death of the baby, while milder forms, but lasting for a long time, can cause delays in physical and mental development. There is a possibility of repeated manifestations of Hyaline-Membrane disease in one or more subsequent children in the family. However, with successful treatment of the neonatal period and subsequent prevention, the family can avoid the occurrence of recurrent hyaline membrane disease at a later stage of development, although science has not made significant progress in this area since the late twentieth century.
Neonatal hyaline membrane disease is a serious condition that requires immediate medical attention. It manifests itself as pneumonia in a newborn baby and occurs as a result of asphyxia caused by suffocation or infection. The disease has several forms and can vary in severity.
Signs of the disease The disease begins in newborns with